Correlation Between Aquestive Therapeutics and 90320LAG2

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and 90320LAG2 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and 90320LAG2 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and UPC HLDG BV, you can compare the effects of market volatilities on Aquestive Therapeutics and 90320LAG2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 90320LAG2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 90320LAG2.

Diversification Opportunities for Aquestive Therapeutics and 90320LAG2

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Aquestive and 90320LAG2 is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and UPC HLDG BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UPC HLDG BV and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 90320LAG2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UPC HLDG BV has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 90320LAG2 go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and 90320LAG2

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the 90320LAG2. In addition to that, Aquestive Therapeutics is 4.69 times more volatile than UPC HLDG BV. It trades about -0.17 of its total potential returns per unit of risk. UPC HLDG BV is currently generating about -0.23 per unit of volatility. If you would invest  9,875  in UPC HLDG BV on August 25, 2024 and sell it today you would lose (345.00) from holding UPC HLDG BV or give up 3.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy73.91%
ValuesDaily Returns

Aquestive Therapeutics  vs.  UPC HLDG BV

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Aquestive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
UPC HLDG BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UPC HLDG BV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90320LAG2 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Aquestive Therapeutics and 90320LAG2 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and 90320LAG2

The main advantage of trading using opposite Aquestive Therapeutics and 90320LAG2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 90320LAG2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90320LAG2 will offset losses from the drop in 90320LAG2's long position.
The idea behind Aquestive Therapeutics and UPC HLDG BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bonds Directory
Find actively traded corporate debentures issued by US companies